🔎 Trials Near Me

Akèy › Dyabèt Tip 2 › Texas › Pharr

Etid klinik pou Dyabèt Tip 2 nan Pharr, TX

8 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote Pharr (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Ap rekriteFaz 3
  • Texas Valley Clinical Research, Weslaco · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Ap rekriteFaz 3
  • Texas Valley Clinical Research, Weslaco · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07754461

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3
  • AURORA-2 Clinical Site, Weslaco · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Ap rekriteFaz 2
  • Texas Valley Clinical Research, Weslaco · 12 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT06897475

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Ap rekriteFaz 2
  • Texas Valley Clinical Research, LLC, Weslaco · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Ap rekriteFaz 2
  • Texas Valley Clinical Research, Weslaco · 12 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT07215559

Etid Dyabèt Tip 2 nan lòt vil

Lòt etid nan Pharr

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.